GLP3-RT 30mg

This compound is a novel synthetic peptide engineered to act as a triagonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Its multi-receptor pharmacology has positioned it as a compound of significant research interest in the study of energy homeostasis, hepatic function, and integrated metabolic signaling. This 30mg lyophilized preparation supports research protocols requiring higher peptide quantities. Intended strictly for in vitro research and laboratory investigation. Not for human consumption.